Technische Daten
Change(s) made:Complete revision
Status:Research Use Only (RUO)
Ig Unterklasse:IgG
Immunogen:Synthetic peptide of human Nm23
Vorbehandlung:ProTaqs® Antigen Enhancer I (Cat. No. 401602092) or ProTaqs® Antigen Enhancer IV (Cat. No. 401602392)
Zelluläre Lokalisation:Cytoplasmic, nuclear
Kontrolle:Breast cancer
Synonyme:nucleoside dIPhosphatase kinase A, AWD, AWD, drosophila, homolog of, GAAD, Granzyme A activated DNase, GZMA activated DNase, Metastasis inhibition factor nm23, NB, NBS, NDK A, NDP kinase A, KDKA, NDPK-A, NDPKA, NDPKB, NM23, NM23 H1, NM23 long variant, included, NM23-H1, NM23-M1, NM23B, NM23H1B, NM23H1B, included, NME1, NME1-NME2 spliced read-through transcript, included, NME2, Non metastatic cells 1 protein, Non-metastatic cells 1, protein (NM23A) expressed in, Nonmetastatic cells 1, protein expressed in, Nonmetastatic protein 23, Nonmetastatic protein 23, homolog 1, Nucleoside diphosphate kinase A, Tumor metastatic process associated protein, Tumor metastatic process-associated protein.
Verfügbar in folgenden Ländern:worldwide

Nm23, a housekeeping enzyme, is a nucleoside diphosphate kinase A. It was the first identified metastasis suppressor protein. Nm23 prolongs disease-free survival and is associated with a good prognosis in breast cancer patients.